93 reports

  • Global Tuberculosis (TB) Drugs Market is Expected to Grow to $1,035.67 mn by 2021
  • 2.1 Preface

About Tuberculosis Drug Tuberculosis (TB) is caused by Mycobacterium tuberculosis and often affects the lungs. It spreads from person to person through the air in the form of a cough, sneeze or spit. TB affects adults more when compared with children. Technavio’s analysts forecast the global tuberculosis drug market to...

  • Pathology
  • Tuberculosis
  • World
  • Forecast
  • Sandoz Inc.
  • Profiles of Tuberculosis Drugs Producers
  • Tuberculosis Treatment Drugs Market Overview

China’s demand for Tuberculosis Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Tuberculosis
  • China
  • Demand
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Tuberculosis Treatment Drugs Market Overview
  • Tuberculosis Treatment Drugs Market Overview

This study focuses on China’s Tuberculosis Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Tuberculosis
  • China
  • Demand
  • Trade
  • Chongqing Huapont Pharmaceutical Co., Ltd
  • Profiles of Tuberculosis Drugs Producers
  • Chapter VII TUBERCULOSIS TREATMENT DRUGS PRODUCER DIRECTORY

This study focuses on China’s Tuberculosis Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy....

  • Tuberculosis
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Shenyang Shuangding Pharmaceutical Co., Ltd.

Tuberculosis Testing Market, Nucleic Acid Testing, Xpert Test, Serological Tests, and Smear Microscopy - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025 Section ## Preface ##. ##.

  • Pathology
  • Tuberculosis
  • APAC
  • World
  • Company Financials

Global Tuberculosis Diagnosis and Treatment Market Research and Forecast 2017-2022 ##.

  • Pathology
  • Tuberculosis
  • World
  • Market Size

Tuberculosis Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Pathology
  • Tuberculosis
  • APAC
  • World
  • Demand

Based on Type, the market is categorized into Latent Tuberculosis, Active Tuberculosis and Drug-resistant Tuberculosis.

  • Anti-Infective
  • Tuberculosis
  • World
  • Forecast
  • Market Size

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Tuberculosis
  • Europe
  • Japan
  • United States
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • World
  • Demand

One unit refers to one Mycobacterium Diagnostic test.

  • Tuberculosis
  • Australasia
  • Demand
  • Market Size
  • Supply

North America tuberculosis Drugs/ Therapeutics market, 2014 - 2025 (USD Million) ##. ##. ## U. S. ##. ##. ##. ## U. S. tuberculosis Drugs/ Therapeutics market, 2014 - 2025 (USD Million) ##. ##. ## Canada ##. ##. ##. ## Canada tuberculosis Drugs/ Therapeutics market, 2014 - 2025 (USD mil

  • Therapy
  • Tuberculosis
  • United States
  • Forecast
  • Market Size

Based on Therapeutics the market is categorized into Tuberculosis Drugs (First Line) and Tuberculosis Drugs (Second Line).

  • Therapy
  • Tuberculosis
  • United States
  • World
  • Forecast

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Forecast

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Infectious Disease
  • Respiratory Disease
  • Tuberculosis
  • Europe
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug resistance in TB patients undergoing treatment.

  • Diagnostics
  • Pathology
  • Tuberculosis
  • United States
  • Market Size

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Forecast
  • APAC Tuberculosis Vaccines Market
  • APAC Tuberculosis Vaccines Market Overview

Executive Summary Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand...

  • Tuberculosis
  • World
  • Market Size
  • Merck & Co., Inc.
  • Sanofi S.A.
  • 2.6.4 Tuberculosis
  • 2.4.4 Tuberculosis

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market Summary Respiratory complications are a diverse set of indications that include respiratory disorders, cardiovascular disorders and infectious diseases. They...

  • Tuberculosis
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.

Emerging Infectious Disease Diagnostic Technologies ##.

  • Pathology
  • Tuberculosis
  • Demand

## Market Snapshot: Global Tuberculosis Testing Market TABLE ## Global Tuberculosis Testing Market Revenue, by Test Type, 2012 – 2020 (USD Million) TABLE ## Global Tuberculosis Testing Market Revenue, by Geography, 2012 – 2020 (USD Million) TABLE ## North America

  • Pathology
  • Tuberculosis
  • World
  • Company Financials
  • Market Size
  • 6.1.1 May 21, 2018: Oxford Immunotec's T-SPOT.TB Test Included in the World Health Organization's First-Ever Essential Diagnostics List

" Despite steady progress in reducing the burden of tuberculosis in recent decades, TB remains a major global health problem and one of the top ## causes of death worldwide, " said Dr.

  • Tuberculosis
  • United Kingdom
  • Market Size
  • DENTSPLY Sirona Inc.
  • Ivoclar Vivadent AG
  • Epistem Holdings Plc Pipeline Products by Indication
  • Oct 28, 2014: Successful completion of Genedrive Indian clinical trials and regulatory submission

Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a biopharmaceutical and biotechnology company is a molecular diagnostics company which also provides contract research services to other pharmaceutical companies. It also undertakes the development of novel therapies for cancer treatment and wound healing. It provides...

  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company
  • TUBERCULOSIS VACCINE
  • TUBERCULOSIS VACCINE - DRUG PROFILE

Tuberculosis - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Pipeline Review, H2 2017, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape. Tuberculosis, commonly known as TB,...

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.
  • DESCRIPTION OF INFECTIONS
  • GLOBAL POPULATION AT RISK FOR SERIOUS BACTERIAL INFECTIONS, SECONDARY TO CHRONIC DISEASES BY SELECTED GEOGRAPHICAL REGION

One third of the world' s current population has been infected with M. tuberculosis, and new infections occur at a rate of one per second.

  • Tuberculosis
  • Cepheid
  • Getinge Group
  • Roche Group
  • STERIS Corporation
  • PULMONARY TUBERCULOSIS THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2018*
  • PULMONARY TUBERCULOSIS THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2018*

Pulmonary Tuberculosis Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Pulmonary Tuberculosis Global Clinical Trials Review, H1, 2018" provides an overview of Pulmonary Tuberculosis clinical trials scenario.This report provides top line data relating to the clinical...

  • Anti-Infective
  • Clinical Trial
  • Tuberculosis
  • World
  • Product Initiative
  • Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
  • 08.2 Next-generation Nucleic Acid Detection

Introduction TB is an infectious disease caused by the bacterium, Mycobacterium tuberculosis.

  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Roche Group